Temasek Holdings
PE consortium completes take-private of China's WuXi PharmaTech
A consortium comprising the founder and CEO of WuXi PharmaTech and several PE investors has completed the privatization of the China-based provider of contract R&D services to global pharmaceutical companies.
AVCJ Awards 2015: Deal of the Year - Late Stage Technology: Didi Kuaidi
Having raised $3 billion in the largest-ever private funding round for a start-up, newly-merged Didi Kuaidi is looking to put past rivalries behind it
CPPIB, Temasek join $7b pre-IPO round for China's PSBC
Canada Pension Plan Investment Board (CPPIB) and Temasek Holdings have participated in a RMB45.1 billion ($7.5 billion) pre-IPO funding round for The Postal Savings Bank of China (PSBC)
Singapore biotech firm Aslan Pharma raises $34m
Singapore-based biotech developer Aslan Pharmaceuticals has raised $34 million in a Series C round led by Accuron Technologies, a subsidiary of government-sponsored investment firm Temasek Holdings.
HNA invests $500m in PE-backed China tour operator Tuniu
China’s HNA Tourism Group has agreed to invest $500 million for a 24.1% stake in Tuniu, a US-listed Chinese online package tour provider that has several PE and VC investors.
Chinese online education platform TutorGroup raises $200m
TutorGroup, a Chinese online education platform, has raised $200 million in a Series C round of funding from new investors including GIC Private and the Russia-China Investment Fund (RCIF).
Premji, Temasek pay $296m for stake in ICICI's life insurance unit
PremjiInvest - the family office of Wipro Enterprises chairman Azim Premji - and Singapore's Temasek Holdings have agreed to pay INR19.5 billion ($296 million) for a 6% stake in the life insurance unit of ICICI Bank.
Temasek, Hillhouse lead $150m round for China's Aiwujiwu
Aiwujiwu, a Chinese rental and second-home listings portal, has completed a Series E round of funding worth $150 million round led by Temasek Holdings and Hillhouse Capital.
WuXi Pharmatech wins endorsement for PE-backed take-private
The proposed privatization of WuXi PharmaTech, a China-based provider of contract R&D services to the global pharmaceutical sector, has won the support of two major shareholder proxy advisory firms.
Temasek, Silver Lake back Dell in $67b acquisition of EMC
Singapore's Temasek Holdings is supporting the $67 billion acquisition of data storage and cloud computing company EMC Corporation by US-based computer maker Dell. Other backers include Silver Lake and MSD Partners.
Temasek, Vy Capital lead $60m round for India's Zomato
Temasek Holdings and existing investor Vy Capital have committed $60 million in funding to Indian online restaurant and event guide Zomato.
MBK consortium to buy Tesco's Homeplus in $6.4b deal
A consortium led by MBK Partners has agreed to buy Homeplus – Tesco’s South Korea unit – at an enterprise valuation of GBP4.2 billion ($6.4 billion). Canada Pension Plan Investment Board (CPPIB) will contribute $534 million to the deal. Other co-investors...
MBK named preferred bidder for Tesco's Korea business - report
A consortium led by MBK Partners is said to have been named the preferred bidder for Tesco’s South Korea-based Homeplus business in a deal that could be worth around $6 billion.
Softbank, Foxconn, Alibaba lead $500m round for Snapdeal
SoftBank Group, Foxconn Technology Group and Alibaba Group have led a $500 million investment in Indian online marketplace Snapdeal.
GIC's PE allocation unchanged as 12-month overall return rises
GIC Private’s PE allocation remained static at 9% last year as the Singapore sovereign wealth fund posted a 20-year annualized return of 4.9% for the 12 months ended March 2015, up from 4.1% in 2014.
PE backers set for partial exits in HealthCare Global's India IPO
HealthCare Global Enterprises (HCG), a private equity-backed Indian cancer care hospital chain, has filed for an IPO.
Singapore's Temasek, UOB to offer $500m in venture debt
Singapore's government-sponsored investment fund Temasek Holdings and United Overseas Bank (UOB) have agreed to form a joint vehicle which will offer $500 million in venture debt financing to start-ups in China, India and Southeast Asia.
China taxi app operator Didi Kuaidi raises record-breaking $2b
Chinese mobile ride-hailing app operator Didi Kuaidi has raised $2 billion in a round including new investors Ping An Ventures and Capital International Private Equity Fund. The transaction is understood to be the largest ever fundraising by a private...
Singapore's Temasek, CVC agree $2b deal for US generic drug firm
Singapore's Temasek Holdings is a member of a CVC Capital Partners-led consortium that has agreed to buy a controlling stake in US-based generic drug manufacturer Alvogen. The deal is said to value the company at $2 billion.
Temasek's India NBFC to provide home financing
Fullerton India Credit Company (FICC), the Indian non-banking financial company (NBFC) owned by Singapore's Temasek Holdings, will set up a new unit offering home financing in the affordable housing segment.
Go Scale sets up PE exit of China's Lattice Power
Go Scale Capital has led a transaction whereby a majority stake in its Chinese portfolio company, Lattice Power, has been sold to Shunfeng International Clean Energy (SFCE). The sellers will receive HK$2.04 billion ($263 million) worth of shares in Hong...
China tour provider gets $500m from JD.com, PE investors
Tuniu, a US-listed Chinese online package tour provider, has agreed to raise $500 million through a private placement to e-commerce giant JD.com and several of its existing PE and VC backers.
Advent, Temasek to buy Crompton Greaves' consumer unit
Advent International and Temasek Holdings have agreed to buy a 34.37% stake in the consumer products unit of India’s Crompton Greaves from Avantha Group. The deal values the business at INR66 billion ($1.07 billion).
KKR, Anchor buy controlling stake Korea's Ticket Monster
A consortium led by KKR and Anchor Equity Partners has agreed to buy a controlling stake in South Korean mobile e-commerce company Ticket Monster from US-listed Groupon for $360 million.